Poultry Vaccine Technology Platforms

Area of Science:

• Veterinary Virology
• Vaccinology
• Biotechnology

Background:

• Poultry farming relies heavily on vaccination to prevent economically significant diseases.
• Classical vaccine technologies (live attenuated, inactivated) have limitations in efficacy and safety.
• Emerging biotechnologies offer novel platforms for poultry vaccine development.

Purpose of the Study:

• To review diverse technology platforms for poultry vaccine production.
• To compare the properties, advantages, and limitations of various vaccine types.
• To focus on viral disease vaccines and market-authorized technologies.

Main Methods:

• Review of scientific literature on poultry vaccine technologies.
• Analysis of classical and modern vaccine development approaches.
• Evaluation of genetic engineering, subunit, vector, and nucleic acid-based platforms.

Main Results:

• Live attenuated and inactivated vaccines represent classical approaches.
• Genetic engineering enables modified live/inactivated vaccines via deletion, mutation, insertion, or chimerization.
• Subunit, vector, and nucleic acid vaccines utilize specific pathogen genes for induced protection.

Conclusions:

• Novel vaccine platforms offer improved specificity and safety profiles.
• Market-authorized technologies demonstrate the practical success of advanced vaccine strategies.
• Continued innovation in poultry vaccinology is crucial for disease control.